Alice K. Jacobs, MD
Boston University School of Medicine
Dept of Medicine
Cardiovascular Medicine

MD, Saint Louis University

A professor of medicine and the Director of the Cardiac Catheterization Laboratory and Interventional Cardiology at Boston Medical Center, has been very involved in the American Heart Association. On a national level at the AHA, she is currently President -Elect, chair of the Professional Education Committee, a member of the Science Advisory Coordinating Committee and chair of the Council on Clinical Cardiology Program Committee. She is also involved in local AHA activities and currently serves as President of the Northeast Affiliate. In addition, Dr. Jacobs plays an active role in the American College of Cardiology. She has been a member of several ACC writing groups establishing training criteria in interventional cardiology, assessing and maintaining competence in interventional cardiology and updating guidelines for the performance of percutaneous coronary intervention. In addition, she is a member of the American Board of Internal Medicine Interventional Cardiology Test Committee and the ACC/AHA Task Force on Practice Guidelines. Dr. Jacobs' major research activities are in the area of invasive cardiology and revascularization strategies. Currently she is the site principal investigator of several multi-center trials including the NHLBI funded BARI 2-D, SHOCK, and OAT trials and the NHLBI Dynamic Registry. She is also active in the area of heart disease in women and has evaluated the acute and long-term outcomes of percutaneous coronary intervention in women in comparison to men.

Expertise includes: Interventional Cardiology; Coronary revascularization; Sex-based differences in cardiovascular disease.

2011-2011 LUMEN Conference: Recognition for advancing the care of patients with STEMI

A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment...
08/22/2013 - 12/31/2018 (PI)
Abbott Laboratories

A prospective, multi-center, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy (DAPT) in subjects undergoing percutaneous c
05/01/2010 - 04/30/2015 (PI)
Harvard Clinical Research Institute

Gravitas: Gauging Responsivness with a Verify Now Assay-Impact on Thrombsis and Safety
10/01/2008 - 09/30/2012 (PI)

Xience V Everolimus Eluting Coronary Stent System Post-Approval Study (EECSS)
09/01/2008 - 05/31/2012 (PI)
Abbott Laboratories

Tilarginine Acetate Injection in a Randomized International Study in Unstable AMI Patients / Cardiogenic Shock
07/01/2005 - 06/30/2007 (PI)

D.E.S. Cover Registry
04/13/2005 - 04/12/2007 (PI)
Cordis Corporation

The GUARD Trial Saphenous Vein Graft Intervention Using AngioGuard for Reduction of Distal Embolization
11/29/2000 - 12/31/2005 (PI)
Cordis Corporation

Clopidogrel for Reduction of Events During Observation (CREDO)
08/25/2000 - 08/31/2001 (PI)
Sanofi Pharmaceuticals Inc (from Cleveland Clinic Foundation) Bristol-Myers Squibb

XaNADU PCI Pilot Trial
01/22/2001 - 05/31/2001 (PI)
Duke University

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Hannan EL, Samadashvili Z, Cozzens K, Berger PB, Chikwe J, Jacobs AK, Walford G, Ling FSK, Venditti FJ, Gold J, King SB. 2017 Versus 2012 Appropriate Use Criteria for Percutaneous Coronary Interventions: Impact on Appropriateness Ratings. JACC Cardiovasc Interv. 2018 Mar 12; 11(5):473-478. PMID: 29519380.
  2. Levine GN, Dai X, Henry TD, Calfon Press M, Denktas AE, Garberich RF, Jacobs AK, Jaski BE, Kaul P, Kontos MC, Stouffer GA, Smith SC. In-Hospital ST-Segment Elevation Myocardial Infarction: Improving Diagnosis, Triage, and Treatment. JAMA Cardiol. 2018 Feb 21. PMID: 29466558.
  3. Hannan EL, Zhong Y, Berger PB, Jacobs AK, Walford G, Ling FSK, Venditti FJ, King SB. Association of Coronary Vessel Characteristics With Outcome in Patients With Percutaneous Coronary Interventions With Incomplete Revascularization. JAMA Cardiol. 2018 Feb 01; 3(2):123-130. PMID: 29282471.
  4. Langabeer JR, Henry TD, Fowler R, Champagne-Langabeer T, Kim J, Jacobs AK. Sex-Based Differences in Discharge Disposition and Outcomes for ST-Segment Elevation Myocardial Infarction Patients Within a Regional Network. J Womens Health (Larchmt). 2018 Jan 10. PMID: 29319393.
  5. Koshy LM, Aberle LH, Krucoff MW, Hess CN, Mazzaferri E, Jolly SS, Jacobs A, Gibson CM, Mehran R, Gilchrist IC, Rao SV. Comparison of Radial Access, Guided Femoral Access, and Non-Guided Femoral Access Among Women Undergoing Percutaneous Coronary Intervention. J Invasive Cardiol. 2018 01; 30(1):18-22. PMID: 29035844.
  6. van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, Kilic A, Menon V, Ohman EM, Sweitzer NK, Thiele H, Washam JB, Cohen MG. Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association. Circulation. 2017 Oct 17; 136(16):e232-e268. PMID: 28923988.
  7. Hannan EL, Samadashvili Z, Cozzens K, Gesten F, Osinaga A, Fish DG, Donahue CL, Bass RJ, Walford G, Jacobs AK, Venditti FJ, Stamato NJ, Berger PB, Sharma S, King SB. Changes in Percutaneous Coronary Interventions Deemed "Inappropriate" by Appropriate Use Criteria. J Am Coll Cardiol. 2017 Mar 14; 69(10):1234-1242. PMID: 28279289; DOI: 10.1016/j.jacc.2016.12.025;.
  8. Hannan EL, Zhong Y, Cozzens K, Gesten F, Friedrich M, Berger PB, Jacobs AK, Walford G, Ling FS, Venditti FJ, King SB. The Impact of Excluding Shock Patients on Hospital and Physician Risk-Adjusted Mortality Rates for Percutaneous Coronary Interventions: The Implications for Public Reporting. JACC Cardiovasc Interv. 2017 Feb 13; 10(3):224-231. PMID: 28183462; DOI: 10.1016/j.jcin.2016.10.040;.
  9. Hannan EL, Zhong Y, Jacobs AK, Ling FSK, Berger PB, Walford G, Venditti FJ, King SB. Incomplete revascularization for percutaneous coronary interventions: Variation among operators, and association with operator and hospital characteristics. Am Heart J. 2017 Apr; 186:118-126. PMID: 28454825.
  10. Jacobs AK. The Challenge to Implement Systems of Care for ST-Segment-Elevation Myocardial Infarction. Circulation. 2016 Aug 02; 134(5):375-7. PMID: 27482001; DOI: 10.1161/CIRCULATIONAHA.116.023834;.
Showing 10 of 350 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 340 publications over 37 distinct years, with a maximum of 28 publications in 2006

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

acute coronary syndromes
angioplasty, percutaneous transluminal
coronary artery disease
Contact for Mentoring:

88 E. Newton St Newton Pavilion
Boston MA 02118
Google Map

Jacobs's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department